Validation of Aspiration Markers in Intubated Patients
Withdrawn before enrolling · Phase 1
Conditions studied: Pneumonia, Aspiration
In brief
The goal of this interventional study is to test Quinine as marker of aspiration (endotracheal tube \[ETT\] cuff leakage) in mechanically ventilated, critically ill patients.
Key facts
- Study ID
- NCT02598713
- Run by
- Massachusetts General Hospital
- People needed
- 0
- Starts
- 2015-12-01
- Expected to finish
- 2024-06-30
- Last updated by the study team
- 2025-12-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Admission to Surgical ICUs (MGH Ellison 4 or Blake 12)
- Patients expected to be intubated for at least 48 hours or longer from the time of enrollment.
You may not qualify if…
- High PEEP requirement at enrollment (PEEP higher than 8 cmH2O)
- Diagnosis of ARDS (any severity)
- Status asthmatics
- Current or past participation in another interventional trial conflicting with the present study
- Pregnant women
- Prisoner status
- Patients who had partial or total gastrectomy.
Where it is running
- Massachussets General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.